Airborne Particulate Matter and Systemic Inflammation: Mechanisms, Health Impacts, and Public Health Implications

Abstract

Airborne particulate matter (PM) is a major component of air pollution and represents a significant global public health concern. Fine and ultrafine particles derived from traffic emissions, industrial processes, biomass burning, and natural sources can penetrate deep into the respiratory tract and, in some cases, enter the systemic circulation. Increasing evidence links exposure to particulate matter, particularly PM2.5 and ultrafine particles, with systemic inflammation, a key underlying mechanism in the development of cardiovascular disease, metabolic disorders, respiratory conditions, and neurodegenerative diseases. This review examines the sources and characteristics of airborne particulate matter, the biological mechanisms that connect inhaled particles to systemic inflammatory responses, and the clinical and epidemiological evidence supporting these associations. Key pathways include oxidative stress, activation of innate immune responses, endothelial dysfunction, and dysregulation of autonomic balance. The role of vulnerable populations and long-term health consequences is discussed, along with emerging biomarkers of exposure and inflammation. Finally, the review highlights policy and public health interventions aimed at reducing exposure and mitigating inflammatory health effects. Understanding the relationship between airborne particulate matter and systemic inflammation is critical for developing effective preventive strategies and reducing the global burden of pollution-related diseases. Keywords: Particulate matter, Systemic inflammation, Oxidative stress, Cardiovascular disease, Air pollution.